Biogen’s Alzheimer’s drug approved by FDA, first new therapy in nearly two decades
By: CNBC
FDA grant conditional approval to BIIB’s Alzheimer’s drug. The first in almost two decades.
In approving the drug on a conditional basis, is the agency embarking in a new era? Can this standard be applied to other devastating diseases? Time will tell.
Congrats to the millions and millions of Alzheimer patients and care givers!
